Cargando…

BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model

Bromodomain-containing protein 4 (BRD4) is an intracellular protein that regulates expression of various cellular functions. This study investigated whether BRD4 inhibition can alter the immunomodulatory and antitumor effects of radiation therapy (RT). A murine breast cancer cell line was implanted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seongmin, Jeon, Seung Hyuck, Han, Min Guk, Kang, Mi Hyun, Kim, In Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487493/ https://www.ncbi.nlm.nih.gov/pubmed/37685868 http://dx.doi.org/10.3390/ijms241713062

Ejemplares similares

Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model
por: Han, Min Guk, et al.
Publicado: (2022)

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects
por: Kim, Young Hun, et al.
Publicado: (2021)

BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages
por: Li, Xi, et al.
Publicado: (2020)

Inhibition of BRD4 Promotes Pexophagy by Increasing ROS and ATM Activation
por: Kim, Yong Hwan, et al.
Publicado: (2022)

Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
por: Kim, Kyoung-Jin, et al.
Publicado: (2017)

Radiation therapy enhances systemic antitumor efficacy in PD-L1 therapy regardless of sequence of radiation in murine osteosarcoma
por: Katsuki, Shohei, et al.
Publicado: (2022)

Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer
por: Shen, Hao, et al.
Publicado: (2022)

Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma
por: Jeong, Keun-Yeong, et al.
Publicado: (2015)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models
por: Jin, Won Jong, et al.
Publicado: (2023)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019)

Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression
por: Tan, Yifan, et al.
Publicado: (2018)

CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers
por: Lee, Shin-Wha, et al.
Publicado: (2023)

Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
por: Jeon, Insu, et al.
Publicado: (2020)

Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
por: Yuan, Meng, et al.
Publicado: (2022)

The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma
por: Feng, Mei, et al.
Publicado: (2023)

BRD4 inhibition for the treatment of pathological organ fibrosis
por: Stratton, Matthew S., et al.
Publicado: (2017)

Inhibiting BRD4 to generate BETter T cell memory
por: Kasmani, Moujtaba Y., et al.
Publicado: (2021)

Unexpected BrdU inhibition on astrocyte-to-neuron conversion
por: Wang, Tao, et al.
Publicado: (2021)

Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes
por: Larue, Ross C., et al.
Publicado: (2014)

NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling
por: Ka, Na-Lee, et al.
Publicado: (2023)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes
por: Sun, Xiaohui, et al.
Publicado: (2021)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis
por: Jang, Bum-Sup, et al.
Publicado: (2022)

BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)

Radiation Dose Escalation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma
por: Takenaka, Wataru, et al.
Publicado: (2020)

Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts
por: Cardnell, Robert J. G., et al.
Publicado: (2011)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in Arabidopsis
por: Jarończyk, Kamila, et al.
Publicado: (2021)

BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis
por: Hu, Yuan, et al.
Publicado: (2015)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis
por: Kim, Seongyeong, et al.
Publicado: (2017)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma
por: Lasso, Paola, et al.
Publicado: (2023)

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma
por: Tiago, Manoela, et al.
Publicado: (2020)

BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma
por: Li, Mengna, et al.
Publicado: (2023)

BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02nmv7db6h0m6djhk12mion30e